Strides Pharma Science Limited
Strides Pharma Science Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: STAR and BSE: 532531 (ISIN INE939A01011).
It has a market capitalisation of ₹9,487 crore, a last close of ₹1,029 on 2026-10-19, a one-year return of 28.8%.
Valuation: a price-to-earnings ratio of 15.46x, a price-to-book ratio of 3.05x, a dividend yield of 0.5%.
Profitability: return on equity of 19.7%, return on capital employed of 22.6%, an operating margin of 18.7%.
Growth: sales growth of 9.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.54x, promoter holding of 29.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 9,487 |
| Last close | ₹1,029 |
| P/E (TTM) | 15.46x |
| P/B | 3.05x |
| Dividend yield | 0.5% |
| ROE (FY) | 19.7% |
| ROCE (FY) | 22.6% |
| Operating margin (TTM) | 18.7% |
| Sales growth, 3-year CAGR | 9.6% |
| Debt / equity | 0.54x |
| Promoter holding | 29.0% |
| 1-year return | 28.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means